Neuropathic Pain News and Research

RSS
Neuropathic pain is a type of pain that is caused by damage to the nervous system following an injury or illness and affects approximately 1% of the population.

Further Reading

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Lonza, Benitec partner to develop scalable manufacturing process for AAV-based viral gene therapies

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Nerve damage caused by leprosy linked to changes in the brain of patients

Nerve damage caused by leprosy linked to changes in the brain of patients

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Medical case report of woman with Channelopathy-associated Insensitivity to Pain Syndrome

Medical case report of woman with Channelopathy-associated Insensitivity to Pain Syndrome

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec Biopharma announces closing of U.S. initial public offering of ADSs

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Benitec prices initial public offering of 1,500,000 American Depositary Shares

Hiroshima University researchers reveal molecular mechanisms involved in neuropathic pain

Hiroshima University researchers reveal molecular mechanisms involved in neuropathic pain

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

Immune Pharmaceuticals amends licensing agreement with Endo Pharmaceuticals

UC Davis scientists identify significant driver of neuropathic pain

UC Davis scientists identify significant driver of neuropathic pain

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Spinifex Pharmaceuticals enters into agreement to be acquired by Novartis

Spinifex Pharmaceuticals enters into agreement to be acquired by Novartis

Cannabis and Cannabinoid Research journal supports President Obama's statement on medical use of marijuana

Cannabis and Cannabinoid Research journal supports President Obama's statement on medical use of marijuana

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

Immune Pharmaceuticals begins bertilimumab Phase II clinical trials in Bullous Pemphigoid, Ulcerative Colitis

FASEB honors Max Planck Florida scientist with Glaxo Smith Kline Neuroscience Discovery Award

FASEB honors Max Planck Florida scientist with Glaxo Smith Kline Neuroscience Discovery Award

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

INS announces winners of inaugural best abstract competition at 12th World Congress

INS announces winners of inaugural best abstract competition at 12th World Congress

International Neuromodulation Society recognizes third Giant of Neuromodulation

International Neuromodulation Society recognizes third Giant of Neuromodulation

Weekly sessions of non-invasive brain stimulation improve outcomes in patients with post-stroke pain

Weekly sessions of non-invasive brain stimulation improve outcomes in patients with post-stroke pain